Lisa L. Dietz
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy.
Journal: Vaccine
Published: August 21, 2025
Utilizing immunotherapy towards achieving a functional cure for HIV-1.
Journal: Current opinion in HIV and AIDS
Published: April 30, 2024
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 22, 2024
Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection.
Journal: The Journal of infectious diseases
Published: January 05, 2024
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection.
Journal: iScience
Published: June 09, 2023
Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 22, 2023
Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines.
Journal: Frontiers in medicine
Published: July 14, 2022
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity.
Journal: Communications medicine
Published: June 30, 2022
An Extended PD-L2 Cytoplasmic Domain Results From Alternative Splicing in NSCLC Cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: May 25, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026